COVID-19 and Immunodeficiency

Corona viruses a type of virus that causes respiratory disorder such as the common cold to more   acute diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Majority of people with immune deficiencies and those on immune-suppressing drugs are immune compromised, putting them at a higher risk of respiratory diseases. The most common symptomatic primary immunodeficiency in adults is common element immunodeficiency. Affected patients do not establish an adequate humoral react to community-acquired viral illnesses, and recent researches have found evidence that these patients are more susceptible to severe SARS-CoV-2 infections. The injection of COVID-19 convalescent plasma could be varying in treatment technique in this case.

  • Primary immunodeficiency
  • SARS-CoV-2
  • COVID-19 convalescent plasma
  • Genetic defects
  • Covid-19 Alpha variant

  • Primary immunodeficiency
  • COVID-19 convalescent plasma
  • SARS-CoV-2
  • Genetic defects

Related Conference of COVID-19 and Immunodeficiency

April 04-05, 2024

38th International Conference on Immunology

Madrid, Spain
May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland

COVID-19 and Immunodeficiency Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in